National Cancer Institute; Notice of Closed Meetings, 1707 [2012-263]

Download as PDF Federal Register / Vol. 77, No. 7 / Wednesday, January 11, 2012 / Notices Date: February 2, 2012. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Nikko San Francisco, 222 Mason Street, San Francisco, CA 94102. Contact Person: Edwin C Clayton, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5180, MSC 7844, Bethesda, MD 20892, (301) 408– 9041, claytone@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Intercellular Interactions Study Section. Date: February 8, 2012. Time: 8 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, Washington, DC 20037. Contact Person: Wallace Ip, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, (301) 435– 1191, ipws@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 5, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–382 Filed 1–10–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: January 3, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health National Cancer Institute; Notice of Closed Meetings pmangrum on DSK3VPTVN1PROD with NOTICES Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Robert Bird, Ph.D., Chief, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8113, Bethesda, MD 20892–8328, (301) 496–7978, birdr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts. Date: February 21, 2012. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Rm. 707, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Lalita D. Palekar, Ph.D., Scientific Review Officer, Special Review And Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892, (301) 496–7575, palekarl@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) [FR Doc. 2012–263 Filed 1–10–12; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. BILLING CODE 4140–01–P Name of Committee: National Cancer Institute Special Emphasis Panel; Review of an R25 and a K01 Application. Date: February 2, 2012. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. SUMMARY: VerDate Mar<15>2010 15:02 Jan 10, 2012 Jkt 226001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Toxicology Program (NTP) Final Process for Preparation of the Report on Carcinogens (RoC) Division of the National Toxicology Program (DNTP), National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), HHS. ACTION: Notice. AGENCY: The NTP announces the final process for preparation of the RoC. The process is available on the NTP Web site (https://ntp.niehs.nih.gov/go/rocprocess) or by contacting Dr. Ruth Lunn (see ADDRESSES). PO 00000 Frm 00043 Fmt 4703 Sfmt 9990 1707 Dr. Ruth Lunn, Director, Office of the Report on Carcinogens, DNTP, NIEHS, P.O. Box 12233 MD K2– 14, Research Triangle Park, NC 27709; telephone: (919) 316–4637 or email: lunn@niehs.nih.gov. Courier address: NIEHS, Room 2138, 530 Davis Drive, Morrisville, NC 27560. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Ruth Lunn (see ADDRESSES). Dr. SUPPLEMENTARY INFORMATION: Background Information on the Process On October 31, 2011, the NTP released its proposed process for preparation of the RoC (76 FR 67200 and 76 FR 71037) and invited written public comment. The NTP also held a listening session on November 29, 2011, to receive oral comment on the proposed process. The NTP considered all input, made some revisions, and presented a revised process at the NTP Board of Scientific Counselors public meeting (76 FR 68461) on December 15, 2011 (https://ntp.niehs.nih.gov/go/9741). The NTP now announces the final process for preparation of the RoC. The RoC process is available on the NTP Web site (https://ntp.niehs.nih.gov/go/ rocprocess) or by contacting Dr. Lunn (see ADDRESSES). Background Information on the RoC The RoC is a science-based, public health document, required by Congress to be published every two years (Public Health Services Act sec. 301(b)(4), 42 U.S.C. 241(b)(4)). It identifies agents, substances, mixtures, and exposure circumstances (hereafter referred to as ‘‘substances’’) in our environment that may potentially put people in the United States at increased risk for cancer. Each edition of the report is cumulative and includes newly listed substances in addition to those listed in previous editions (for more information see https://ntp.niehs.nih.gov/go/roc). Substances are listed in the report as either known or reasonably anticipated human carcinogens. The NTP prepares the RoC on behalf of the Secretary of Health and Human Services. The 12th RoC was published in June 2011 (https://ntp.niehs.nih.gov/go/roc12). Dated: December 21, 2011. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2012–395 Filed 1–10–12; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 77, Number 7 (Wednesday, January 11, 2012)]
[Notices]
[Page 1707]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-263]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Review of an R25 and a K01 Application.
    Date: February 2, 2012.
    Time: 1 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Robert Bird, Ph.D., Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, 6116 Executive Boulevard, Room 8113, Bethesda, MD 
20892-8328, (301) 496-7978, birdr@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Core Infrastructure and Methodological Research for Cancer 
Epidemiology Cohorts.
    Date: February 21, 2012.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rm. 707, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, Ph.D., Scientific Review 
Officer, Special Review And Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7141, Bethesda, MD 20892, (301) 496-7575, 
palekarl@mail.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 3, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-263 Filed 1-10-12; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.